Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03592914 · ClinicalTrials.gov registry record
Respiratory Rate Accuracy Verification Clinical: Pulmonary Rehabilitation Patients
A clinical trial, sponsored by Nonin Medical.
- Completed
- Registry status
- 60
- Enrollment target
NCT03592914: Completed study, sponsored by Nonin Medical.
NCT03592914 is a clinical trial that has completed, run by Nonin Medical. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03592914 has completed, sponsored by Nonin Medical.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Study Design: This study is a comparative, single-center study. This is a minimal risk study (as defined in 21 CFR Part 56) using a non-significant risk device (as defined in 21 CFR Part 812.3). A minimum of 60 subjects will be enrolled in the study. Subject participation will last approximately 1 hour.
Primary Outcome
Measure respiratory rates
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-07-31 |
| Est. Completion | 2019-01-16 |
What the finished NCT03592914 record still lists
NCT03592914 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03592914 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03592914 about?
NCT03592914 is a clinical study titled "Respiratory Rate Accuracy Verification Clinical: Pulmonary Rehabilitation Patients". Study Design: This study is a comparative, single-center study. This is a minimal risk study (as defined in 21 CFR Part 56) using a non-significant risk device (as defined in 21 CFR Part 812.3). A minimum of 60 subjects will be enrolled in the study. Subject participation will last approximately 1 h...
What is the current status of trial NCT03592914?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2018-07-31. Estimated completion is 2019-01-16.
Who is sponsoring clinical trial NCT03592914?
This trial is sponsored by Nonin Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI